Combined immunodeficiency caused by a loss-of-function mutation in DNA polymerase delta 1.

Ye Cui, Sevgi Keles, Louis-Marie Charbonnier, Amélie M Julé, Lauren Henderson, Seyma Celikbilek Celik, Ismail Reisli, Chen Shen, Wen Jun Xie, Klaus Schmitz-Abe, Hao Wu, Talal A Chatila

Journal: The Journal of allergy and clinical immunology 2020;145(1):391-401.e8

PMID: 31629014

Abstract

BACKGROUND

Mutations affecting DNA polymerases have been implicated in genomic instability and cancer development, but the mechanisms by which they can affect the immune system remain largely unexplored.

OBJECTIVE

We sought to establish the role of DNA polymerase δ1 catalytic subunit (POLD1) as the cause of a primary immunodeficiency in an extended kindred.

METHODS

We performed whole-exome and targeted gene sequencing, lymphocyte characterization, molecular and functional analyses of the DNA polymerase δ (Polδ) complex, and T- and B-cell antigen receptor repertoire analysis.

RESULTS

We identified a missense mutation (c. 3178C>T; p.R1060C) in POLD1 in 3 related subjects who presented with recurrent, especially herpetic, infections and T-cell lymphopenia with impaired T-cell but not B-cell proliferation. The mutation destabilizes the Polδ complex, leading to ineffective recruitment of replication factor C to initiate DNA replication. Molecular dynamics simulation revealed that the R1060C mutation disrupts the intramolecular interaction between the POLD1 CysB motif and the catalytic domain and also between POLD1 and the Polδ subunit POLD2. The patients exhibited decreased numbers of naive CD4 and especially CD8 T cells in favor of effector memory subpopulations. This skewing was associated with oligoclonality and restricted T-cell receptor β-chain V-J pairing in CD8 but not CD4 T cells, suggesting that POLD1 differentially affects peripheral CD8 T-cell expansion and possibly thymic selection.

CONCLUSION

These results identify gene defects in POLD1 as a novel cause of T-cell immunodeficiency.

Copyright © 2019 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Address: Division of Immunology, Boston Children's Hospital, and the Department of Pediatrics, Harvard Medical School, Boston, Mass.; Necmettin Erbakan University, Meram Medical Faculty, Division of Pediatric Allergy and Immunology, Konya, Turkey.; Program in Molecular and Cellular Medicine, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Mass; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Mass.; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Mass.; Division of Newborn Medicine and Neonatal Genomics Program, Boston Children's Hospital, Harvard Medical School, Boston, Mass.; Division of Immunology, Boston Children's Hospital, and the Department of Pediatrics, Harvard Medical School, Boston, Mass; Program in Molecular and Cellular Medicine, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Mass.; Division of Immunology, Boston Children's Hospital, and the Department of Pediatrics, Harvard Medical School, Boston, Mass. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.